Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1H-imidazoyl-based compounds as antileishmanial agents
- 3 February 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 149 (4) , 490-495
Abstract
Cutaneous leishmaniasis (CL) is a spectrum of clinical manifestations characterized by severe skin ulcerations that leads to social stigma. There are limited treatment options for CL, and the available drugs are becoming less efficacious due to drug resistance. More efficacious and safer antileishmanial drugs are needed. In this study, the biological effect of seven synthetically accessible nitroaromatic compounds was evaluated in vitro against amastigotes of Leishmania amazonensis, followed by in vivo evaluation using mouse models of CL. Two compounds (6 and 7) were active against amastigotes in vitro [half-maximal effective concentration (EC50): 4.57 ± 0.08 and 9.19 ± 0.68 μm, respectively], with selectivity indexes >50, and the other compounds were not selective. In vivo, compounds 6 and 7 (10 mg kg−1, twice a day for 14 days) failed to reduce skin lesion sizes and parasite loads determined by light microscopy of lesion imprints and quantitative polymerase chain reaction. Nevertheless, the in vitro leishmanicidal efficacy sustained their use as templates for nitroimidazole-based antileishmanial drug discovery programmes focusing on analogues with more suitable properties.Keywords
Funding Information
- Fundação Oswaldo Cruz
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 20 references indexed in Scilit:
- Social and Economic Burden of Human LeishmaniasisThe American Journal of Tropical Medicine and Hygiene, 2016
- Hit and lead criteria in drug discovery for infectious diseases of the developing worldNature Reviews Drug Discovery, 2015
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based SignaturesJournal of Medicinal Chemistry, 2015
- Cutaneous Leishmaniasis: Recent Developments in Diagnosis and ManagementAmerican Journal of Clinical Dermatology, 2015
- American tegumentary leishmaniasis: correlations among immunological, histopathological and clinical parametersAnais Brasileiros de Dermatologia, 2014
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c miceInternational Journal of Antimicrobial Agents, 2012
- Generation of a Set of Simple, Interpretable ADMET Rules of ThumbJournal of Medicinal Chemistry, 2008
- Making Medical HistoryBulletin of the History of Medicine, 2006
- The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in AmazoniaMemórias do Instituto Oswaldo Cruz, 1994